Description
Product Category : User Cases
Format : PDF
Ensuring Drug Safety Post-Approval with AI-Driven Surveillance.
AI-powered patient safety monitoring involves analyzing post-market surveillance data, real-world evidence, and patient feedback to detect and report adverse events related to medications. This early detection helps biopharma companies respond quickly to potential safety concerns, maintaining patient safety and regulatory compliance.
